LuxS (S-ribosylhomocysteinase) catalyzes the cleavage of the thioether linkage of S-ribosylhomocysteine (SRH) to produce homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD), the precursor to a small signaling molecule that mediates interspecies bacterial communication called autoinducer 2 (AI-2). Inhibitors of LuxS should interfere with bacterial interspecies communication and potentially provide a novel class of antibacterial agents. In this work, SRH analogues containing substitution of a nitrogen atom for the endocyclic oxygen as well as various deoxyriboses were synthesized and evaluated for LuxS inhibition. Two of the [4-aza]SRH analogues showed modest competitive inhibition (K I $40 lM), while most of the others were inactive. One compound that contains a hemiaminal moiety exhibited time-dependent inhibition, consistent with enzyme-catalyzed ring opening and conversion into a more potent species (K I ⁄ = 3.5 lM). The structure-activity relationship of the designed inhibitors highlights the importance of both the homocysteine and ribose moieties for high-affinity binding to LuxS active site.
complexation with borate to form a furanosyl borate diester, which acts as the AI-2 in some bacteria. 11, 12 Chemical synthesis of the unstable DPD has been accomplished recently by the groups of Janda 13 and Semmelhack, 14 which allowed the vital complexation properties of DPD with borate 15 to be studied and provided DPD as a reliable standard for investigation of AI-2 regulated QS processes. LuxS is a small metalloenzyme (157 amino acids in the Bacillus subtilis enzyme) containing Fe 2+ coordinated by His-54, His-58, Cys-126, and a water molecule. The native enzyme is unstable under aerobic conditions, but substitution of Co 2+ for Fe 2+ gives a highly stable variant with essentially wild-type catalytic activity. [16] [17] [18] In the proposed catalytic mechanism, LuxS catalyzes consecutive aldose-ketose (1a ? 1b) and ketose-ketose (1b ? 1c) isomerization steps and then b-elimination of Hcy from a 3-keto intermediate (1c ? 1d) to form DPD. 11, 19 LuxS-catalyzed cleavage of the C5-S thioether bond in SRH is analogous to that of SAH hydrolase, which effects cleavage of an equivalent thioether bond in SAH by first oxidizing the C3 0 secondary alcohol into a ketone with an NAD + cofactor. 20, 21 Zhou and co-workers designed and synthesized two LuxS substrate analogues, the S-(anhydroribosyl)-L-homocysteine (2) and S-(homoribosyl)-L-cysteine compounds, which blocked initial and final mechanistic steps, respectively (Fig. 2) . 22 Pei and co-workers have prepared a series of stable analogues of the putative enediolate intermediate, some of which showed submicromolar inhibition of the enzyme (e.g., K I = 0.72 lM for isostere 3). 23 Zhang et al. found that the brominated furanones 4 covalently modify and inactivate LuxS. 24 Recognizing structural similarities between substrates of mammalian AdoHcy hydrolase and bacterial able hydroxyl group at C3 were found to be competitive substrate of LuxS. 26, 27 The time dependence inhibition with C3 halogenated substrates was caused by enzyme-catalyzed elimination of halide ions. 27 Here, we report synthesis of [4-aza] SRH mimics in which the furanose ring oxygen has been replaced by a nitrogen atom. The resulting hemiaminals should have different stabilities 28 relative to the O,O-hemiacetals present in SRH and as a result different rates of metabolic alteration. The higher basicity of the aza analogues is expected to have different binding strengths and rates for productions of the open chain aldehyde form-necessary for the first isomerization to occur. Also, the aminosugars can be protonated at physiological pH and the corresponding positive charge may have an effect on binding to the enzymatic active site. Azasugars 29 have been found to be potent inhibitors of glycosidases and glycosyltransferases 30, 31 and have been targeted as transition-state models. 32 , 33 The 4 0 -azanucleosides 34 function as transition-state inhibitors of MTAN at the femtomolar level.
35,36
2. Results and discussion
Chemistry
Our first target was 1,4-dideoxy-[4-aza]SRH 12 lacking the hydroxyl group at C1 (Scheme 1). Compound 12 cannot undergo ring opening (which will preclude the initial step of the LuxS-catalyzed reaction) and may act as a competitive inhibitor of LuxS. Synthesis of 12 started with the protected 1-amino-1,4-anhydro-1-deoxy-D-ribitol 6, which was readily prepared from the commercially available D-gulonic acid c-lactone. 37 However, attempted mesylation of the N-benzyl protected 6 resulted in the formation of piperidine derivative 13 as a mixture of two diastereomers ($3:1). Presumably, the mesylated pyrrolidine underwent a rearrangement reaction into the piperidines through an aziridine intermediates. 38, 39 We found that replacement of the benzyl protecting group at ring nitrogen of 6 with a Boc group suppressed the nucleophilicity of the nitrogen and prevented ring expansion, allowing the formation of stable 5-O-mesyl derivatives. Thus, silylation of 6 with TBDMSCl and subsequent hydrogenation (5% Pd/C) in the presence of (Boc) 2 O 39,40 yielded 8 (97% from 5). Desilylation of 8 (70%) followed by mesylation gave 10 as a stable compound (96%). Displacement of the mesylate group with a thiolate, generated by reduction of properly protected L-homocystine 19 with water soluble tris(2-carboxyethyl)phosphine hydrochloride, 26 gave thioether 11 (86%). Treatment of 11 with TFA effected simultaneous removal of the N-Boc, acetonide and t-butyl ester protection groups to give the desired [4-aza] SRH analogue 12 in good yields (66%).
The second target was c-lactam 21 , which contains an amide carbonyl at C1 and nitrogen as a replacement of the ring oxygen (Scheme 2). It is noteworthy that, as opposed to the [4- 41 produced N-benzyl lactam 14a (65%) and a small amount (18%) of the corresponding N-benzoylpyrrolidinone byproduct, resulted from oxidation of the benzylic carbon of the N-protecting group. Desilylation of 14a with TBAF, followed by mesylation and displacement of the mesylate group with protected Hcy gave Scheme 2. Reagents and conditions: (a) NaIO 4 (Fig. 3a) , with a K I value of 48 lM (Table 1) . Similarly, lactam 21 also behaved as a competitive inhibitor with K I value of 37 lM. As expected, the lactam 20, which contains a bulky benzyl group at the ring nitrogen, was found to be inactive, likely due to steric reasons. Compounds 36 and 38 were both inactive toward LuxS, highlighting the importance of the ribose hydroxyl groups for enzyme binding. The proposed mechanism predicts that the C2 and C3 hydroxyl groups directly coordinate with the catalytic metal ion during different catalytic steps (Fig. 1 ). The lack of activity of compound 43, which contains a methyl group instead of a hydroxyl group at the C1 position, may be caused by both loss of favorable interactions with the OH group and the bulky size of the methyl group. Collectively, these results suggest that proper interactions between the ribose ring and the enzyme active site critically contribute to the formation of a productive E-S complex and subsequent catalysis.
Unlike the other analogues described above, inhibition of LuxS by the hemiaminal-containing analogue 23 was time dependent (Fig. 3b) . Its inhibition kinetics can be described by the slow-binding equation
where K I is the equilibrium constant for the formation of the initial EÁI complex, k is the rate constant for the conversion of the EÁI complex to the tighter EÁI ⁄ complex, and K I ⁄ represents the dissociation constant of the EÁI ⁄ complex. To assess its potency, different concentrations of compound 23 were preincubated with LuxS for 30 min at 4°C and the residual enzymatic activity was measured. Plot of the residual activity against the inhibitor concentration resulted in an IC 50 value of 60 lM, from which a K I ⁄ value of 3.5 lM was estimated (Table 1) .
Unfortunately, the complex inhibition kinetics precluded an accurate determination of the K I value. While further work is clearly necessary to determine the exact mechanism of inhibition by 23, we propose a working hypothesis to explain the observed time dependence (Fig. 4) . Since compounds 12 and 21, which are structurally similar to 23, did not exhibit time-dependent inhibition and our model study shows that the hemiaminal 25a exists in equilibrium with the free aldehyde form (25b), we propose that hemiaminal 23 may undergo ring opening to form aldehyde 23a. Due to its structural similarity to catalytic intermediate 1a ( Fig. 1 The remaining compound 28 and its ancestor lactam showed no significant inhibition of LuxS.
Conclusions
We have synthesized [4- 
Experimental procedure
To a stirred solution of 6 37 (150 mg, 0.57 mmol) in anhydrous CH 2 Cl 2 (5 mL) at rt under Ar atmosphere were added DMAP (7 mg, 0.05 mmol) and imidazole (93 mg, 1.36 mmol) followed by TBDMSCl (103 mg, 0.68 mmol). The mixture was then stirred for 
A solution of 7 (145 mg, 0.38 mmol), triethylamine (0.105 mL, 0.76 mmol), di-tert-butyldicarbonate (126 mg, 0.57 mmol) and Pd/C (5%, 300 mg) in ethanol (6 mL) was stirred under an atmosphere of hydrogen at room temperature for 6 h. The reaction mixture was filtered through Celite to remove the catalyst. The Celite was washed with ethanol (5 mL) and washings and the filtrate were combined and evaporated. The residue was partitioned (EtOAc//ÁNaHCO 3 /H 2 O). The organic layer was washed (brine), dried (MgSO 4 ) and evaporated. The residue was column chromatographed (20 ? 30% EtOAc/hexane) to give 8 (147 mg, 99%) with spectral properties as reported.
TBAF (1 M/THF; 0.25 mL, 0.25 mmol) was added to a stirred solution of 8 (66 mg, 0.17 mmol) in THF (5 mL) at ambient temperature. After stirring for 30 min, the reaction mixture was partitioned (EtOAc//ÁNaHCO 3 /H 2 O). The organic layer was washed (brine), dried (MgSO 4 ) and evaporated. The residue was column chromatographed (50 ? 60% EtOAc/hexane) to give 9 (32 mg, 70%) with spectral properties as reported. (60 mg, 0.22 mmole) in anhydrous CH 2 Cl 2 (6 mL) at 0°C (ice-bath). After 5 min, ice-bath was removed and the reaction mixture was allowed to stir at ambient temperature for 30 min. The reaction mixture was quenched with saturated NaHCO 3 /H 2 O and was extracted with CH 2 Cl 2. The organic layer was washed (brine), dried (MgSO 4 ) and evaporated to give 10 (73 mg, 96%) as a mixture ($3:2) of two rotamers of sufficient purity to be directly used in next step: 1 
S-(
Procedure B.
Step a. H 2 O (0.4 mL) and tris(2-carboxyethyl)phosphine hydrochloride (140 mg, 0.5 mmol) were added to a stirred solution of N,N'-di(tert-butoxycarbonyl)-L-homocystine di(tert-butyl) ester 19 
Procedure C.
Step a. Compound 11 (39 mg, 0.07 mmol) dissolved in TFA (4.0 mL) was stirred at 0°C for 3 h. Volatiles were coevaporated with toluene to give an oily residue, which was used directly in next step.
Step b. Product from step a was treated with TFA/H 2 O (9:1, 4.0 mL) for 1 h at 0°C. Volatiles were evaporated and the crude product was purified on RP-HPLC (5% CH 3 CN/H 2 O at 2.5 mL/min; t R = 12 min) to give 12 (12 mg, 66%) as a colorless oil: 
4-Amino-N-benzyl-4-deoxy-2,3-O-isopropylidene-D-ribono-1,4-lactam (14b)
TBAF (1 M/THF; 0.18 mL, 0.18 mmol) was added dropwise to a stirred solution of 14a (49 mg, 0.12 mmol) in THF (10 mL) at 0°C. After 5 min, the ice-bath was removed and reaction mixture was allowed to stir at ambient temperature for 2 h. The reaction mixture was quenched with water and volatiles were evaporated. The residue was partitioned (EtOAc//ÁNaHCO 3 /H 2 O) and the organic layer was washed (brine), dried (MgSO 4 ) and evaporated. 
4-Amino-N-tert-butoxycarbonyl-5-O-tert-butyldimethylsilyl-4-deoxy-2,3-O-isopropylidene-D-ribono-1,4-lactam (15a)
Oxidation of 8 (90 mg, 0.23 mmol) with NaIO 4 (126 mg, 0.7 mmol) and RuO 2 ÁxH 2 O (8 mg, 0.05 mmol) by Procedure D [column chromatography (50 ? 60% EtOAc/hexane)] gave 15a (56 mg, 60%) as a colorless oil with data as reported. 44 
4-Amino-N-tert-butoxycarbonyl-4-deoxy-2,3-Oisopropylidene-D-ribono-1,4-lactam (15b)
Desilylation of 15a (50 mg, 0.12 mmol) with TBAF (1 M/THF, 0.14 mL, 0.14 mmol), as described for 14b, [column chromatography (70 ? 80% EtOAc/hexane)] gave 15b (27 mg, 77%) as a colorless oil: 
4-Amino-N-benzyl-4-deoxy-2,3-O-isopropylidene-5-Omethanesulfonyl-D-ribono-1,4-lactam (16)
Mesylation of 14b (67 mg, 0.24 mmol) with MsCl (27 lL, 
4-Amino-N-tert-butoxycarbonyl-5-O-methanesulfonyl-4-deoxy-2,3-O-isopropylidene-D-ribono-1,4-lactam (17)
Oxidation of Compound 33 (9 mg, 0.02 mmol) was dissolved in TFA (0.7 mL), and the resulting mixture was stirred at ambient temperature for 60 min. The reaction mixture was evaporated, and coevaporated with toluene to give a trifluoroacetate of 34 (7.5 mg, 95%) as a colorless oil: 38 (s, 3), 1.41 (s, 3), 2.10-2.20 (m, 1, H8 
S-(
To a solution of 7 (109 mg, 0.28 mmol) in EtOH (6 mL) was added 5% Pd/C (300 mg) and stirred under an atmosphere of H 2 at room temperature for 6 h. The mixture was filtered through Celite to remove the catalyst. The Celite bed was washed with ethanol (5 mL) and the filtrate and washings were combined and evaporated. The residue was column chromatographed (30% EtOAc/hexane) to give 44 50 as a colorless oil (70 mg, 80%). A stirred solution of 44 (70 mg, 0.24 mmol) and SeO 2 (0.01 mmol, 1.1 mg) in acetone (3 mL) was cooled to À4°C under N 2 atmosphere and H 2 O 2 (25%) was added slowly (3-4 h) until the reaction was completed (as judged by TLC). Volatiles are evaporated and the residue was partitioned (EtOAc//NaHCO 3 /H 2 O).The organic layer was collected, washed (brine) and dried (MgSO 4 ). The resulting solid was chromatographed (50% EtOAc/hexane) to give 45 (54 mg, 73%) as a white solid with data as reported. ) in a Perkin-Elmer k20 UV-vis spectrophotometer at room temperature.
For compounds that showed time dependent inhibition, the inhibitor and LuxS (1.6 lM) were preincubated for 30 min at 4°C and the reaction was then initiated by addition of SRH.
